Grincamycin B, a Streptomyces lusitanus-derived natural product, inhibits glioma cell proliferation and invasion by suppressing PI3K/AKT and alkaline phosphatase (PHOA) signaling [379]. This evidence concerns the gene AKT1 and glioma.